Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis.

Zhang, Sirui; Li, Yupei; Liu, Guina; Su, Baihai

Zhang, Sirui; Li, Yupei; Liu, Guina; Su, Baihai.

Affiliation

Zhang S; West China School of Medicine, Sichuan University, 610041, Chengdu, China.
Li Y; Department of Nephrology, Med+ Biomaterial Institute, West China Hospital, Sichuan University, 610041, Chengdu, China.
Liu G; Institute for Disaster Management and Reconstruction, Sichuan University, 610207, Chengdu, China.
Su B; West China School of Medicine, Sichuan University, 610041, Chengdu, China.

Thromb J ; 19(1): 91, 2021 Nov 24.

Article in En | MEDLINE | ID: mdl-34819094

Key words

Anticoagulation; Bleeding; COVID-19; Meta-analysis; Mortality; Thromboprophylaxis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Thromb J Year: 2021 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google